Galapagos, NovAliX join forces for integrated drug discovery
Under the agreement, NovAliX will assume Galapagos’ research capabilities in Romainville, while the latter will retain the flexibility…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
31 Mar 23
Under the agreement, NovAliX will assume Galapagos’ research capabilities in Romainville, while the latter will retain the flexibility…
30 Mar 23
The prescription-to-OTC approval is backed by Human Factors study data, an updated Drug Facts label, pharmacovigilance data gathered…
29 Mar 23
The TYK2 inhibitor showed superior efficacy in improving skin clearance compared to placebo and twice-daily Otezla in the…
28 Mar 23
Built under the partnership between Thermo Fisher and UCSF, the facility will focus on cell therapies for difficult…
24 Mar 23
Based on the results of the mid-stage trial, the company is advancing the clinical programme of upadacitinib in…
23 Mar 23
The approval was based on clinical data from the global ReSTORE phase 3 trial and is also backed…
20 Mar 23
Accounting for less than 2% of its total global workforce of over 25,000, the latest move is Amgen’s…
17 Mar 23
The dermatology brands sold by Dr. Reddy's to Eris Lifesciences include Hydroheal, Revilus, Avarta, Aquaderm, and others
16 Mar 23
The antiviral is now going into phase 2 clinical studies for both the prevention and treatment of dengue
14 Mar 23
The deal is expected to allow for combining potential across the pipelines of both firms and will make…